We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
09 Dec 2022 - 11 Dec 2022

Novel Hemostatic Agent Treats Trauma Victims On-Site

By HospiMedica International staff writers
Posted on 13 Aug 2020
Print article
Circulating HAPPI increases blood clot formation (Photo courtesy of Harvard University)
Circulating HAPPI increases blood clot formation (Photo courtesy of Harvard University)
A new study shows how a polymer-based systemic clotting agent binds to activated platelets and enhances their accumulation at a wound site.

Developed at Harvard University (Harvard; Cambridge, MA, USA), Case Western Reserve University (CWRU; Cleveland, OH, USA), and other institutions, the injectable hemostatic agent via polymer peptide interfusion (HAPPI) is a hyaluronic acid conjugate with both a collagen-binding peptide and a von Willebrand factor–binding peptide. The polymer-peptide conjugate selectively binds to damaged blood vessels and activated platelets at the bleeding site, promoting their accumulation at the wound site.

In vivo studies in mouse tail vein laceration model demonstrated a reduction of about 99% in bleeding time and about a 97% reduction in blood loss. A 284% improvement in the survival time was observed in a rat inferior vena cava traumatic model, with the injection of HAPPI increasing the median survival rate beyond one hour, a critical goal for trauma care. According to the researchers, lyophilized HAPPI could be stably stored at room temperature for several months and can be reconstituted during therapeutic intervention on demand. The study was published on July 31, 2020, in Science Advances.

“A lot of trauma-related deaths happen within the first hour when blood loss is happening profusely and there is no intervention,” said co-first author Yongsheng Gao, PhD, of the Harvard School of Engineering and Applied Sciences (SEAS). “A key objective for first responders is to keep trauma patients alive during this so-called golden hour, and in that time bring them to a hospital, because once they get to the hospital, it's a different game altogether.”

As most deaths occur during the initial hour after a traumatic injury, hemostatic intervention within the first hour can determine survival in trauma patients. However, current on-site interventions such as tourniquets and topical dressings can only be used to treat externally accessible, compressible wounds. Some advancements have been made in the development of intratissue or intracavitary injectable, self-expandable hemostatic polymer foam technologies such as the RevMedx (Wilsonville, OR, USA) XStat device.

Related Links:

Harvard University
Case Western Reserve University
BMP Whole Blood Analyzer: GEM Premier ChemSTAT
Gold Supplier
Influenza Type A & B Test
Influenza A+B DUO
Rapid Immunological FOB Test
Fecal Occult Blood Test
Hemolysing Reagent
Dialyse-BA 5D

Print article



view channel
Image: AI transforms smartwatch ECG signals into a diagnostic tool for heart failure (Photo courtesy of Pexels)

AI-Based Smartwatch Accurately Detects Heart Failure Using ECG Signals

People with a weak heart pump might not have symptoms, but this common form of heart disease affects about 2% of the population and 9% of people over 60. When the heart cannot pump enough oxygen-rich blood,... Read more

Surgical Techniques

view channel
Image: CystoSmart image enhancement and AI diagnostic tool will enhance cancer detection (Photo courtesy of Claritas HealthTech)

AI Diagnostic Tool Improves Cancer Detection in Cystoscope Images of Bladder

Bladder cancer is the 10th commonest cancer worldwide and the 6th commonest cancer amongst men. It is known to have high recurrence rates and significant risks of disease progression. Early detection of... Read more

Patient Care

view channel
Image: Automated cleaning system allows endoscopes to be cleaned direct from clinic (Photo courtesy of Aston University)

World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance

Endoscopes are long, thin tubes with a light and camera at one end. Due to the sensitivity of the materials and electronics they cannot be sterilized in an autoclave (a machine that uses steam under pressure),... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more


view channel
Image: The global multiparameter patient monitoring systems market is expected to surpass USD 15 billion by 2028 (Photo courtesy of Unsplash)

Global Multiparameter Patient Monitoring Systems Market Driven by Rising Chronic Illnesses

Multi-parameter patient monitoring equipment is used to assess the vital signs of patients who are suffering from a serious illness. These devices are meant to give the number of data sets on one screen... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.